Literature DB >> 7954658

Expression of mRNA for atrial natriuretic peptide receptor guanylate cyclase (ANPRA) in human retina.

K Pardhasaradhi1, R K Kutty, S Gentleman, G Krishna.   

Abstract

1. Guanylate cyclase plays an important role in the visual cycle. Here we report the mRNA expression for the atrial natriuretic peptide receptor type A form of guanylate cyclase (ANPRA) in human retina. 2. Polymerase chain reaction using two sets of primers on the cDNAs reverse-transcribed from human retinal poly(A)+ RNA amplified two products under two different reaction conditions. The primers used in the reaction were designed from the reported sequence of human placental ANPRA cDNA. 3. Sequencing of the amplified products showed 100% sequence homology to the human placental ANPRA gene. Northern blot analysis indicated the presence of a 4.4-kb ANPRA mRNA in human retina, similar to that present in human brain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7954658     DOI: 10.1007/BF02088585

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  15 in total

Review 1.  The guanylate cyclase/receptor family of proteins.

Authors:  S Schulz; M Chinkers; D L Garbers
Journal:  FASEB J       Date:  1989-07       Impact factor: 5.191

2.  The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family.

Authors:  S Schulz; S Singh; R A Bellet; G Singh; D J Tubb; H Chin; D L Garbers
Journal:  Cell       Date:  1989-09-22       Impact factor: 41.582

3.  Immunoactive atrial natriuretic peptide in the rat eye: molecular forms in anterior uvea and retina.

Authors:  R A Stone; C C Glembotski
Journal:  Biochem Biophys Res Commun       Date:  1986-01-29       Impact factor: 3.575

4.  Primary structure and functional expression of the human receptor for Escherichia coli heat-stable enterotoxin.

Authors:  F J de Sauvage; T R Camerato; D V Goeddel
Journal:  J Biol Chem       Date:  1991-09-25       Impact factor: 5.157

5.  Site-directed mutational analysis of a membrane guanylate cyclase cDNA reveals the atrial natriuretic factor signaling site.

Authors:  T Duda; R M Goraczniak; R K Sharma
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

6.  A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor.

Authors:  M Chinkers; D L Garbers; M S Chang; D G Lowe; H M Chin; D V Goeddel; S Schulz
Journal:  Nature       Date:  1989-03-02       Impact factor: 49.962

7.  Molecular cloning of a retina-specific membrane guanylyl cyclase.

Authors:  A W Shyjan; F J de Sauvage; N A Gillett; D V Goeddel; D G Lowe
Journal:  Neuron       Date:  1992-10       Impact factor: 17.173

8.  Differential laminar expression of particulate and soluble guanylate cyclase genes in rat retina.

Authors:  I Ahmad; C J Barnstable
Journal:  Exp Eye Res       Date:  1993-01       Impact factor: 3.467

9.  Expression of guanylate cyclase-A mRNA in the rat retina: detection using polymerase chain reaction.

Authors:  R K Kutty; R T Fletcher; G J Chader; G Krishna
Journal:  Biochem Biophys Res Commun       Date:  1992-01-31       Impact factor: 3.575

10.  Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction.

Authors:  D G Lowe; M S Chang; R Hellmiss; E Chen; S Singh; D L Garbers; D V Goeddel
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

View more
  2 in total

Review 1.  Ultracytochemistry as a tool for the study of the cellular and subcellular localization of membrane-bound guanylate cyclase (GC) activity. Applicability to both receptor-activated and receptor-independent GC activity.

Authors:  Maria Grazia Rambotti; Antonio Spreca; Ileana Giambanco; Guglielmo Sorci; Rosario Donato
Journal:  Mol Cell Biochem       Date:  2002-01       Impact factor: 3.396

2.  Bicarbonate and Ca(2+) Sensing Modulators Activate Photoreceptor ROS-GC1 Synergistically.

Authors:  Teresa Duda; Alexandre Pertzev; Clint L Makino; Rameshwar K Sharma
Journal:  Front Mol Neurosci       Date:  2016-01-28       Impact factor: 5.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.